Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates
Author:
Affiliation:
1. Citoxlab North America, Laval, Quebec, Canada;
2. SRI Biosciences Inc., Menlo Park, CA, USA;
3. Amgen Inc., Thousand Oaks, CA, USA;
4. Faculty of Veterinary Medicine, Université de Montréal, Quebec, Canada
Funder
National Institute of Allergy and Infectious Diseases within the National Institutes of Health
Publisher
Informa UK Limited
Subject
Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09553002.2019.1625488
Reference37 articles.
1. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor
2. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl
3. Filgrastim Improves Survival in Lethally Irradiated Nonhuman Primates
4. A Nonhuman Primate Model of the Hematopoietic Acute Radiation Syndrome Plus Medical Management
5. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule;International Journal of Radiation Oncology*Biology*Physics;2023-11
2. Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions;Expert Review of Proteomics;2023-10-03
3. The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation;Biomolecules;2023-05-15
4. Radiosensitivity of rhesus nonhuman primates: consideration of sex, supportive care, body weight, and age at time of exposure;Expert Opinion on Drug Discovery;2023-05-08
5. Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation;Blood Advances;2023-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3